[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100648888":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":22,"locations":28,"responsibleParty":55,"collaborators":10,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":10,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":10,"studyType":72,"phases":10,"briefSummary":73,"conditions":74,"keywords":10,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Zhongda Hospital","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Sepsis",null,[12],"Other: No Intervention: Observational Cohort",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"No Intervention: Observational Cohort","No intervention",[9],[19],{"name":20,"affiliation":5,"role":21},"Yi Yang","PRINCIPAL_INVESTIGATOR",[23],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Fei Peng, Dr. PhD.","CONTACT","15950565786","afei0312@163.com",[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Zhongda Hospital, Southeast University","RECRUITING","Nanjing","Jiangsu","210009","China","CN",{"type":38,"coordinates":39},"Point",[40,41],118.77778,32.06167,{"lat":41,"lon":40},[44,46,48,50,53],{"name":45,"role":25,"phone":26,"phoneExt":10,"email":27},"Fei Fei Peng, PhD. MD.",{"name":47,"role":25,"phone":10,"phoneExt":10,"email":27},"Yang",{"name":49,"role":21,"phone":10,"phoneExt":10,"email":10},"Yi Yang, Dr.PhD.",{"name":51,"role":52,"phone":10,"phoneExt":10,"email":10},"Fei Peng, Dr.PhD.","SUB_INVESTIGATOR",{"name":54,"role":52,"phone":10,"phoneExt":10,"email":10},"Zihan Hu, Dr.",{"type":21,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Fei Peng","Principal Investigator","100648888","pyroevsplin3-mediate-lipid-droplet-mitochondrial-coupling-in-sepsis-endothelial-injury-100648888",false,"NCT07727265","PyroEVs\u002FPLIN3 Mediate Lipid Droplet-Mitochondrial Coupling in Sepsis Endothelial Injury","Role and Mechanism of PyroEVs in Regulating Lipid Droplet-Mitochondrial Coupling Via PLIN3 in Sepsis-Induced Vascular Endothelial Cell Injury","Inclusion Criteria:\n\n* a. Presence of confirmed or suspected infection; b. Sequential Organ Failure Assessment (SOFA) score increase ≥ 2 points from baseline; c. Signed informed consent.\n\nExclusion Criteria:\n\n* Age \\\u003C 18 or \\> 80 years, pregnancy, cancer patients, and individuals with diseases potentially complicated by vascular endothelial cell injury.",true,"ALL","18 Years","80 Years",{"count":70,"type":71},180,"ESTIMATED","OBSERVATIONAL","Objective: To investigate the correlation of PyroEVs and PLIN3 with the severity and prognosis of sepsis patients.\n\nParticipants: Sepsis patients meeting the Sepsis 3.0 diagnostic criteria admitted to the Intensive Care Unit of Zhongda Hospital affiliated with Southeast University, as well as healthy volunteers.\n\nInclusion Criteria:\n\n1. Presence of confirmed or suspected infection;\n2. Sequential Organ Failure Assessment (SOFA) score increase ≥ 2 points from baseline;\n3. Signed informed consent. Exclusion Criteria: Age \\\u003C 18 or \\> 80 years, pregnancy, cancer patients, and individuals with diseases potentially complicated by vascular endothelial cell injury.\n\nPrimary outcome: 28-day mortality, SOFA score",[9],"2026-07-24",{"date":77,"type":78},"2026-07-27","ACTUAL",{"date":80,"type":78},"2024-07-01",{"date":82,"type":71},"2026-12-31",{"name":5,"class":6},1]